Clean Energy Fuels Corp. (CLNE) shares are down $1.19 to $7.65 in after-hours trading Monday after the company reported its first-quarter earnings results.
The natural gas provider reported non-GAAP earnings of ($0.32) per share on revenues of $85.8 million, down 10% from a year ago. Analysts were expecting EPS of ($0.25) on revenues of $100.6 million. The company’s net loss for the first quarter of 2015 was $31.1 million, or ($0.34) per share. This compares with a net loss for Q1/14 of $28.6 million, or ($0.30) per share. Clean Energy said lower fuel prices which were driven by lower natural gas commodity costs reduced revenue by approximately $3.7 million in the first quarter of 2015.
Gallons delivered for the period increased 27% to 75.2 million gallons, compared to 59.3 million gallons delivered in the corresponding period in 2014.
Andrew J. Littlefair, Clean Energy’s President and CEO, stated, “I’m pleased with the progress we are making to drive volume growth across our different market sectors. While gasoline and diesel prices declined, so did our commodity cost, and our margins increased despite the depressed oil market.”
On valuation measures, Clean Energy Fuels Corp. shares, which currently have an average 3-month trading volume of 2.77 million shares, trade at a P/E to growth ratio of (0.36). The median Wall Street price target on the name is $5.50 with a high target of $15.00. Currently ticker boasts 2 ‘Buy’ endorsements, compared to 5 ‘Holds’ and 2 ‘Sell’.
Profitability-wise, CLNE has a t-12 profit and operating margin of (20.9%) and (12.46%), respectively. The $798.94 million market cap company reported $92.3 million in cash vs. $695 million in total liabilities in its most recent quarter.
CLNE currently prints a year-to-date return of around 77%.
The chart below shows where the equity has traded over the last 52 weeks.
Impax Laboratories Inc. (IPXL) reported first quarter non-GAAP EPS of $0.09 after the closing bell Monday, compared to the consensus estimate of $0.18. Revenues increased 20.5% from $118.7 million last year to $143.1 million. Analysts expected revenues of $146 million. Q1 gross profit was $52.3 million, marginally higher from $52.1 million a year earlier. The company posted a first-quarter net loss of $6.33 million, or ($0.09) per share, after reporting a profit of $6.42 million, or $0.09 per share, in the same period a year earlier.
“This quarter’s revenues were negatively impacted by the later than anticipated close of the Tower acquisition, the delayed launch of lamotrigine ODT, which was launched in April due to delayed receipt of inventory from our supplier, and the deferred recognition of product sales from the launch of RYTARY. In addition, product sales mix in the combined portfolio as well as costs related to successfully launching RYTARY and the financing of the Tower acquisition led to a reduction in our first quarter earnings,” said in a statement Fred Wilkinson, president and CEO of Impax Laboratories.
Liquidity: As of March 31, 2015, Impax Laboratories’ cash, cash equivalents and short-term investments were $163.1 million, compared to $214.9 million as of December 31, 2014. The company said the decrease is primarily due to the cash used to pay the purchase price in the Tower acquisition.
IPXL shares are currently down $3.60, or 7.81%, to $42.50 on more than 662K shares.
Shares of magicJack VocalTec Ltd. (CALL) rallied nearly 11% to $7.79 after the company released its earnings results on Monday. The VoIP cloud-based communications company reported Q1’15 EPS of $0.31 per share vs. $0.23 consensus on $25.5 million in revenue (vs. $26.2 million estimates) down 27.8% from a year ago. Q1 gross profit was $16 million, down 27% from $22.2 million a year earlier. The company’s net income for the first quarter ended March 31, 2015 came in at $1.3 million, or $0.07 per diluted share, from a $5.3 million, or $0.30 per diluted share, a year earlier. magicJack said that as of March 31, 2015, it had an estimated 2.70 million active subscribers.
“We were pleased with our first quarter results, highlighted by the sequential increase of activations, lower churn and strong free cash flow generation,” commented Gerald Vento, President and CEO of magicJack VocalTec.
Cash and free cash flow: As of March 31, 2015, magicJack VocalTec reported cash and cash equivalents of $82.9 million and no debt. During Q1/15, the Jerusalem, Israel-based firm generated $7.0 million in free cash flow.
Rackspace Hosting, Inc. (RAX) plunged $6.13, or 11.54%, to $47.00 in after-hours trading after it reported fiscal-first 2015 quarter earnings.
The cloud-based web hosting firm handed in earnings of $0.20 per share on revenue of $480.2 million, beating Wall Street EPS estimates of $0.19 per share on revenue of $481 million. Net income for the first quarter was $25.4 million, or $0.18 per share on a diluted basis, as compared to $28.4 million, or $0.20 per share on a diluted basis, for the first quarter of 2014.
For Q1/15, Rackspace’s cash flow from operating activities was $145 million, capex were $90 million, and adjusted free cash flow was $67 million. At the end of the first quarter of 2015, cash and cash equivalents were $276 million.
“We delivered on our promises in the first quarter and are better positioning ourselves to benefit from the rapid growth of the managed cloud market,” CEO Taylor Rhodes said in a statement.
The company said it expects revenue to grow by 1.5% to 2.5% on a constant currency basis in the second quarter. Adjusted EBITDA margins are expected to be between 32% and 34%.